Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews (Q24202563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

Dominic Aldington

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

Eija Kalso

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

2

Sheena Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

7

Michael P T Lunn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

3

R Andrew Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

author name string

Peter Cole

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

Andrew S C Rice

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

Katri Hamunen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

Maija Haanpaa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

11 November 2013

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

page(s)

CD010567

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

Phenytoin for neuropathic pain and fibromyalgia in adults

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Clonazepam for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Lacosamide for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Carbamazepine for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Topiramate for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Oxcarbazepine for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Guidelines for the pharmacological treatment of peripheral neuropathic pain: expert panel recommendations for the middle East region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Combination pharmacotherapy for the treatment of neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The rationale and use of topiramate for treating neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Genetic predisposition of life-threatening antiepileptic-induced skin reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Indirect comparisons of competing interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The teratogenicity of anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences, Rochester, Minnesota, 1945-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Topical lidocaine for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Fibromyalgia and neuropathic pain--differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Lamotrigine in the management of neuropathic pain: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Brain imaging of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Expect analgesic failure; pursue analgesic success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Challenges in design and interpretation of chronic pain trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Duloxetine use in chronic painful conditions--individual patient data responder analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Treatment of neuropathic pain: an overview of recent guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Anorgasmia with gabapentin may be common in older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Epilepsy and erectile dysfunction: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Neuropathic features of joint pain: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Publication bias in meta-analysis: its causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Small fibre pathology in patients with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Anticonvulsant drugs for acute and chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

A new definition of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010567.PUB2

Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883)

21 January 2018

1 reference

12 December 2020

The epidemiology of self-reported fibromyalgia in Canada.

1 reference

12 December 2020

Anti-convulsants and anti-depressants.

1 reference

12 December 2020

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

1 reference

12 December 2020

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures

1 reference

12 December 2020

Is treatment of postherpetic neuralgia in the community consistent with evidence-based recommendations?

1 reference

12 December 2020

Clinical practice guidelines for management of neuropathic pain: expert panel recommendations for South Africa.

1 reference

12 December 2020

10.1002/14651858.CD010567.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

2223180

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

2223180

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6469538&resulttype=core&format=json

14 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

2223180